Stay updated on Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden message, preventing access to the trial details.
    Difference
    18%
    Check dated 2026-09-19T20:22:46.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5. This indicates a minor version update to the page or underlying system.
    Difference
    0.1%
    Check dated 2026-08-29T19:09:45.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    The page shows an updated revision tag from v3.6.4 to v3.6.5, indicating a versioned update to the site content. This appears to be a maintenance/update change in the content management system rather than a substantive modification to the study details.
    Difference
    0.1%
    Check dated 2026-08-08T10:57:38.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.3 to v3.6.4, signaling a minor refresh of the study record.
    Difference
    0.1%
    Check dated 2026-07-25T06:19:45.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.3, replacing Revision: v3.6.2, indicating a small software update to the page. It does not alter the study content or displayed information.
    Difference
    0.1%
    Check dated 2026-07-03T21:50:09.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    The revision label on the page updated from v3.6.0 to v3.6.2, indicating a software update. The study content and navigation remain unchanged.
    Difference
    0.1%
    Check dated 2026-06-26T22:54:46.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.